ATE353653T1 - Verwendung von stanozolol zur herstellung von entzündungshemmenden und antidegenerativen arzneimitteln - Google Patents
Verwendung von stanozolol zur herstellung von entzündungshemmenden und antidegenerativen arzneimittelnInfo
- Publication number
- ATE353653T1 ATE353653T1 AT04017477T AT04017477T ATE353653T1 AT E353653 T1 ATE353653 T1 AT E353653T1 AT 04017477 T AT04017477 T AT 04017477T AT 04017477 T AT04017477 T AT 04017477T AT E353653 T1 ATE353653 T1 AT E353653T1
- Authority
- AT
- Austria
- Prior art keywords
- inflammatory
- stanozolol
- antidegenerative
- drugs
- producing anti
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- LKAJKIOFIWVMDJ-IYRCEVNGSA-N Stanazolol Chemical compound C([C@@H]1CC[C@H]2[C@@H]3CC[C@@]([C@]3(CC[C@@H]2[C@@]1(C)C1)C)(O)C)C2=C1C=NN2 LKAJKIOFIWVMDJ-IYRCEVNGSA-N 0.000 title abstract 2
- 230000001796 anti-degenerative effect Effects 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 229960000912 stanozolol Drugs 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title 1
- 241000282465 Canis Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- 230000003412 degenerative effect Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI20031553 ITMI20031553A1 (it) | 2003-07-29 | 2003-07-29 | Uso dello stanozololo per la preparazione di medicamenti antinfiammatori |
| ITMI20040290 ITMI20040290A1 (it) | 2004-02-20 | 2004-02-20 | Uso dello stanozololo per la preparazione di medicamenti antinfiammatori e antidegenerativi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE353653T1 true ATE353653T1 (de) | 2007-03-15 |
Family
ID=33542716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04017477T ATE353653T1 (de) | 2003-07-29 | 2004-07-23 | Verwendung von stanozolol zur herstellung von entzündungshemmenden und antidegenerativen arzneimitteln |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1502593B1 (de) |
| AT (1) | ATE353653T1 (de) |
| DE (1) | DE602004004698T2 (de) |
| ES (1) | ES2282767T3 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20061609A1 (it) * | 2006-08-10 | 2008-02-11 | Acme Drugs Srl | Formulazioni intrasinoviali di stanozololo |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2109914T3 (es) * | 1988-01-11 | 1998-02-01 | Chaovanee Aroonsakul | Utilizacion de hormonas anabolicas para la fabricacion de una medicina para el tratamiento de la demencia senil y la enfermedad de alzheimer. |
| US6107289A (en) * | 1992-04-21 | 2000-08-22 | The Schepens Eye Research Institute, Inc. | Ocular therapy in keratoconjunctivitis sicca using topically applied androgens or TGF-β |
| EP1806131A3 (de) * | 1996-07-22 | 2007-08-01 | Renovo Limited | Verwendung von Sex-Steroid-Funktionsmodulatoren zur Behandlung von Wunden und fibrotischen Erkrankungen |
| WO2001072307A1 (en) * | 2000-03-29 | 2001-10-04 | The J. David Gladstone Institutes | Methods of treating cognitive decline disease conditions with androgens |
| US20040092494A9 (en) * | 2000-08-30 | 2004-05-13 | Dudley Robert E. | Method of increasing testosterone and related steroid concentrations in women |
-
2004
- 2004-07-23 AT AT04017477T patent/ATE353653T1/de active
- 2004-07-23 ES ES04017477T patent/ES2282767T3/es not_active Expired - Lifetime
- 2004-07-23 EP EP04017477A patent/EP1502593B1/de not_active Expired - Lifetime
- 2004-07-23 DE DE602004004698T patent/DE602004004698T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004004698D1 (de) | 2007-03-29 |
| ES2282767T3 (es) | 2007-10-16 |
| EP1502593A1 (de) | 2005-02-02 |
| DE602004004698T2 (de) | 2007-11-22 |
| EP1502593B1 (de) | 2007-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE432072T1 (de) | Verwendung von adapalen zur behandlung dermatologischer erkrankungen | |
| ATE508114T1 (de) | Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung | |
| CY1113039T1 (el) | Ηλεκτρικο και μηλονικο αλας τρανς-4-(1r,3s)-6-χλωρο-3-φαινυλινδαν-1-υλο)-1,2,2-τριμεθυλοπιπεραζινης και η χρηση ως φαρμακο | |
| DE60216139D1 (de) | Arylharnstoff-verbindungen in kombination mit anderen zytostatisch oder zytotoxisch wirksamen stoffen zur behandlungen menschlicher krebserkrankungen | |
| PE20050255A1 (es) | Nuevas cianotiazolidas y procedimiento para su preparacion como medicamentos | |
| BR0202547A (pt) | Heterociclo-alquilsulfonil-pirazóis como agentes antiinflamatórios/analgésicos | |
| ATE552837T1 (de) | Verwendung von hochdosierten oxazaphosphorin- arzneimitteln zur behandlung von immunstörungen | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| CR8380A (es) | Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos | |
| CY1115082T1 (el) | Υποκατεστημενα παραγωγα 1,3-διφαινυλπροπανιου, παρασκευες και χρησεις αυτων | |
| DE68908971D1 (de) | Verwendung von physiologisch wirksamen Substanzen zur Herstellung von Medikamenten für Gehirn- und Nervenerkrankungen. | |
| CY1110318T1 (el) | Παραγωγα φαινοξυοξικου οξεος | |
| SE0303571D0 (sv) | Medical product for moisture-sensitive medicaments | |
| BRPI0407662B8 (pt) | derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| UY31346A1 (es) | Compuestos que tienen actividad en el receptor m1 y sus usos en medicina | |
| CY1107231T1 (el) | Υποκατεστημενα παραγωγα 4-αμινοκυκλοεξανολης | |
| ATE353653T1 (de) | Verwendung von stanozolol zur herstellung von entzündungshemmenden und antidegenerativen arzneimitteln | |
| ATE529415T1 (de) | Nitrosubstituierte phenylpiperazinverbindungen, deren herstellung und deren verwendung in medikamenten | |
| BR0210401A (pt) | Composto, composição farmacêutica, uso de um composto e método para o tratamento de um distúrbio ou de uma doença de um corpo de animal vivo, incluindo um humano | |
| DE60039579D1 (de) | Humane adulte astrozyten, sowie deren herstellung und verwendung | |
| ATE408602T1 (de) | Monohyroxycarbamezepin zur verwendung bei der herstellung eines medikaments zur behandlung von affektiver psychose, aufmerksamkeits störungen und neuropathischen schmerzen | |
| DE602004025103D1 (de) | Heilkräuterzusammensetzung zur Behandlung von AIDS | |
| DE602004019481D1 (de) | Antiandrogen-Oligonukleotide zur Behandlung von Androgen-verwandten Hautkrankheiten, diese Verbindungen enthaltende pharmazeutische Zusammensetzungen und deren Verwendung | |
| BR0204547A (pt) | Pirazóis de 5-heteroátomo-substituìdo | |
| ATE314853T1 (de) | 5-n-heterocyclyl-1-(4-sulfonyl-phenyl)-1h-pyraz l derivate mit cyclooxygenase 2 (cox-2) hemmender wirkung zur behandlung von entzündlichen erkrankungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1502593 Country of ref document: EP |